Zhiwei Li

Zhiwei Li

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Talanta
Verified
Journal Article
Closed access
WFWenya Feng
Wenya Feng
JQJuan Qiao
Juan Qiao
JJJunfang Jiang
Junfang Jiang
BSBingbing Sun
Bingbing Sun
ZLZhiwei Li
Zhiwei Li
LQLi Qi
Li Qi

1 July 2025 in Food & Medicine Homology
Verified
Journal Article
Open access
PDF file
YJYongshuai Jing
Yongshuai Jing
JHJin-Ying Hu
Jin-Ying Hu
ZWZi-Ying Wang
Zi-Ying Wang
CTCheng Tao
Cheng Tao
SZShi-Lin Zhang
Shi-Lin Zhang
ZLZhiwei Li
Zhiwei Li
Mori Fructus (MF) is the dried fruit of Morus alba L., which is a dual-purpose resource for medicine and food. As one of the main active components of MF, polysaccharides exhibit many biological activities such as immunomodulation, hypoglycaemia effects, liver protection, and regulation of the intestinal flora. In recent years, the extraction and purification methods, structure, biological activity, and structure-activity relationship of Mori Fructus polysaccharides (MFP) have attracted extensive attention. MFP composed of repetitive disaccharide fragments of 1,4-linked α-GalpA and 1,2-linked α-Rhap. Structural information such as extraction yield, molecular weight (Mw), and monosaccharide composition of MFP differs based on the extraction process used. In addition, the Mw, monosaccharide composition, and chemical modification of MFP are closely related to its biological activity. Currently, the research of MFP is still in the primary stage, and further exploration is required to fully reveal their structure and biological functions. This paper systematically reviews the research progress of extraction, purification, structural characterization, and biological activities of MFP, deeply analyzes their structure-activity relationship and product application status, and discusses some existing problems in order to provide support for the further development and utilization of MFP.

14 November 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YJYongshuai Jing
Yongshuai Jing
MLMingsong Li
Mingsong Li
YLYingqi Li
Yingqi Li
TMTeng Ma
Teng Ma
YQYing Qu
Ying Qu
ZLZhiwei Li
Zhiwei Li

1 December 2020 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
XLXiangfei Li
Xiangfei Li
JQJuan Qiao
Juan Qiao
ZLZhiwei Li
Zhiwei Li
LQLi Qi
Li Qi

28 May 2025 in Nanomaterials
Verified
Journal Article
Open access
MYMengdi Yu
Mengdi Yu
XLXuan Liu
Xuan Liu
SWShuqiong Wang
Shuqiong Wang
ZQZiyao Qin
Ziyao Qin
BHBeibei Hu
Beibei Hu
SSShiguo Sun
Shiguo Sun
Deep-seated tumors present significant diagnostic challenges and pose substantial mortality risks due to their occult anatomical localization. Current diagnostic paradigms predominantly depend on conventional imaging modalities; nevertheless, inherent technical constraints persistently compromise diagnostic precision and therapeutic efficacy. In contrast to traditional methodologies, near-infrared (NIR; 700–1700 nm) fluorescence imaging (FLI) demonstrates superior sensitivity and spatiotemporal resolution, facilitating real-time intraoperative visualization and precision-guided surgical interventions. This paper explores fluorescence materials with tailored structures for tumors at different depths. We critically analyze optimization strategies for NIR fluorescence materials while evaluating their comparative advantages in stratified tissue imaging. This study presents a systematic evaluation of NIR fluorescence molecular tomography (FMT) systems and image reconstruction methodologies. These insights provide feasible ideas for detecting and treating tumors at varying depths in clinical practice. Furthermore, the application of NIR fluorescent materials in tumor diagnosis, navigation-guided surgery, and phototherapy (including photothermal, photodynamic, and immunomodulation therapies) is discussed. Finally, the prospects and challenges of clinical transformation are summarized.

1 January 2013 in Asian Journal of Chemistry
Verified
Journal Article
Open access
ZLZhiwei Li
Zhiwei Li
XGXiuxiu Gao
Xiuxiu Gao
ELErdong Liu
Erdong Liu
XJXing Jia
Xing Jia
DFDecai Fu
Decai Fu